Sharp Decline in Investments in Israeli Life Sciences Companies in 2025
A newly published report presents concerning data regarding the state of the Health-Tech industry in Israel. After a year of recovery in 2024, the current year is proving to be challenging for companies in the life sciences sector.
According to the data, there has been a significant 40% decrease in the volume of investments in these companies during 2025. This marks a notable shift in trends, as the industry experienced some growth just a year ago, raising questions about the future of the sector in the near term.
In addition to the overall decline in investments, the report points to another trend of a decrease in the average amount of each deal. This means that health-tech startups are finding it more difficult to raise large sums as they once did, which could impact their ability to develop new technologies.
Despite the challenging data regarding investments, the report notes that the export sector of the life sciences industry remains stable. This figure indicates that Israeli products and services are still in demand in international markets, despite the difficulties in raising capital.
The Israeli industry continues to monitor developments, hoping that the stability in exports will help companies navigate this complex period. Investors and entrepreneurs will need to find new ways to cope with market changes in order to continue their vital work in the healthcare field.